Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9638326 | 0.93 | MEN1 (0.48) | MEN1POLBKMT2AALDH1A1CA1 | |
| SCHEMBL1922610 | 0.90 | — | — | |
| SCHEMBL2026775 | 0.87 | MEN1 (0.52) | MEN1POLBKMT2AALDH1A1CA1 | |
| SCHEMBL28226333 | 0.87 | MEN1 (0.52) | MEN1POLBKMT2AALDH1A1CA1 | |
| SCHEMBL826294 | 0.87 | POLB (0.48) | MEN1POLBKMT2AALDH1A1CA1 | |
| SCHEMBL28197783 | 0.86 | MEN1 (0.42) | MEN1POLBKMT2AALDH1A1TSHR | |
| SCHEMBL11703529 | 0.86 | MEN1 (0.47) | MEN1POLBKMT2AALDH1A1TSHR | |
| Ether SCHEMBL8954038 | 0.84 | POLB (0.54) | MEN1POLBKMT2AALDH1A1CA1 | |
| SCHEMBL20565098 | 0.84 | POLB (0.46) | MEN1POLBKMT2AALDH1A1CA1 | |
| SCHEMBL12441311 | 0.84 | POLB (0.46) | MEN1POLBKMT2AALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113474913-B | Electrochemical device, electronic device, and method for manufacturing electrochemical device | 东莞新能源科技有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-7550606-B2 | 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2009-06-23 | — | — | US | disclosed |
| US-20090023937-A1 | 9-CYANO-SUBSTITUTED PERYLENE-3,4-DICARBOXYLIC ACID MONOIMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2009-01-22 | — | — | US | disclosed |
| US-7446198-B2 | 9-Cyano-substituted perylene-3, 4-dicarboxylic monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-04 | — | — | US | disclosed |
| US-20060229385-A1 | 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023937-A1 | 9-CYANO-SUBSTITUTED PERYLENE-3,4-DICARBOXYLIC ACID MONOIMIDES | CA9, F9, CA13 | MEN1 778/4885POLB 1895/4885KMT2A 1074/4885 |
| US-20060229385-A1 | 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides | CBR3, NR2C2, NR0B2 | MEN1 2929/4885POLB 2493/4885KMT2A 2435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.